CME Group Inc (CME) Stake Lessened by Toronto Dominion Bank
Toronto Dominion Bank decreased its position in CME Group Inc (NASDAQ:CME) by 5.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 248,366 shares of the financial services provider’s stock after selling 13,710 shares during the period. Toronto Dominion Bank’s holdings in CME Group were worth $41,515,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of CME. Xact Kapitalforvaltning AB grew its stake in CME Group by 5.1% during the second quarter. Xact Kapitalforvaltning AB now owns 61,915 shares of the financial services provider’s stock worth $10,149,000 after buying an additional 2,999 shares during the last quarter. Westpac Banking Corp grew its stake in CME Group by 45.1% during the second quarter. Westpac Banking Corp now owns 107,653 shares of the financial services provider’s stock worth $17,646,000 after buying an additional 33,485 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. grew its stake in CME Group by 10.9% during the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 12,445 shares of the financial services provider’s stock worth $2,040,000 after buying an additional 1,222 shares during the last quarter. World Asset Management Inc grew its stake in CME Group by 3.2% during the second quarter. World Asset Management Inc now owns 20,607 shares of the financial services provider’s stock worth $3,378,000 after buying an additional 632 shares during the last quarter. Finally, Amalgamated Bank grew its stake in CME Group by 5.7% during the second quarter. Amalgamated Bank now owns 44,594 shares of the financial services provider’s stock worth $7,310,000 after buying an additional 2,388 shares during the last quarter. Hedge funds and other institutional investors own 83.99% of the company’s stock.
Shares of NASDAQ CME opened at $188.06 on Thursday. CME Group Inc has a fifty-two week low of $139.04 and a fifty-two week high of $190.43. The company has a market capitalization of $63.37 billion, a P/E ratio of 39.43, a price-to-earnings-growth ratio of 2.17 and a beta of 0.49. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be issued a $0.70 dividend. The ex-dividend date of this dividend is Friday, December 7th. This represents a $2.80 annualized dividend and a yield of 1.49%. CME Group’s dividend payout ratio is currently 58.70%.
Several analysts have recently commented on CME shares. Bank of America reissued a “buy” rating and set a $200.00 price target on shares of CME Group in a research note on Monday, November 5th. Wells Fargo & Co increased their price target on shares of CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a research note on Friday, October 26th. Deutsche Bank reissued a “buy” rating and set a $192.00 price target (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, October 9th. Finally, Jefferies Financial Group increased their price target on shares of CME Group to $203.00 and gave the company a “buy” rating in a research note on Monday, October 8th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $182.69.
In other CME Group news, CAO Jack J. Tobin sold 7,820 shares of the stock in a transaction on Wednesday, September 5th. The shares were sold at an average price of $174.87, for a total value of $1,367,483.40. Following the sale, the chief accounting officer now directly owns 17,534 shares in the company, valued at $3,066,170.58. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Thursday, October 11th. The stock was sold at an average price of $179.86, for a total transaction of $449,650.00. Following the completion of the sale, the chief financial officer now owns 32,720 shares in the company, valued at $5,885,019.20. The disclosure for this sale can be found here. Insiders sold 23,572 shares of company stock worth $4,206,309 over the last 90 days. 0.43% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “CME Group Inc (CME) Stake Lessened by Toronto Dominion Bank” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2018/11/15/cme-group-inc-cme-stake-lessened-by-toronto-dominion-bank.html.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Recommended Story: Balance Sheet
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.